The National Institutes of Health (NIH) is offering research grants for the investigation of primary immunodeficiency diseases. This grant aims to enhance understanding, early detection, and treatment strategies for these disorders. The focus is on advancing discovery, characterization, and identifying causes and mechanisms of diseases. Applications are being accepted until May 07, 2021.
Opportunity ID: 301698
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-712 |
| Funding Opportunity Title: | Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 15, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 07, 2021 |
| Current Closing Date for Applications: | May 07, 2021 |
| Archive Date: | Jun 12, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Small businesses State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) County governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments For profit organizations other than small businesses City or township governments Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to advance the discovery and characterization of primary immunodeficiency diseases, to understand the causes and mechanisms of disease, to enable early detection and molecular diagnosis, and to support the development of strategies to treat and eventually cure these disorders. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-712.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00239286 | May 05, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259226 | May 05, 2018 | May 07, 2021 | View |
Package 1
Mandatory forms
301698 RR_SF424_2_0-2.0.pdf
301698 PHS398_CoverPageSupplement_4_0-4.0.pdf
301698 RR_OtherProjectInfo_1_4-1.4.pdf
301698 PerformanceSite_2_0-2.0.pdf
301698 RR_KeyPersonExpanded_2_0-2.0.pdf
301698 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
301698 RR_Budget_1_4-1.4.pdf
301698 RR_SubawardBudget30_1_4-1.4.pdf
301698 PHS398_ModularBudget_1_2-1.2.pdf
301698 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
301698 RR_SF424_2_0-2.0.pdf
301698 PHS398_CoverPageSupplement_5_0-5.0.pdf
301698 RR_OtherProjectInfo_1_4-1.4.pdf
301698 PerformanceSite_2_0-2.0.pdf
301698 RR_KeyPersonExpanded_2_0-2.0.pdf
301698 PHS398_ResearchPlan_4_0-4.0.pdf
301698 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
301698 RR_Budget_1_4-1.4.pdf
301698 RR_SubawardBudget30_1_4-1.4.pdf
301698 PHS398_ModularBudget_1_2-1.2.pdf
301698 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
